AlfuzosinThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2

71 records returned

An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: Based on the analysis of MSHQ scores before and after alfuzosin treatment, improvement was significant on ejaculatory function, in addition to improvement on LUTS and quality of life. MSHQ is a useful tool to evaluate the male sexual dysfunction. (Source: International Journal of Clinical Practice)
Source: International Journal of Clinical Practice - November 4, 2009 Category: Internal Medicine Authors: M. K. Kim, J. Cheon, K. S. Lee, M.K. Chung, J. Y. Lee, S.W. Lee, S. W. Kim, B. H. Chung, K. Park, J. K. Park Source Type: journals

The Effects of Tolterodine Extended Release and Alfuzosin for the Treatment of Double-J Stent–Related SymptomsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Journal of Endourology , Vol. 0, No. 0. (Source: Journal of Endourology)
Source: Journal of Endourology - October 9, 2009 Category: Urology & Nephrology Tags: article Source Type: journals

Alfuzosin for chronic pelvic pain syndrome: Another placebo?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Nirmal T J, Singh J CIndian Journal of Urology 2009 25(3):423-423 (Source: Indian Journal of Urology)
Source: Indian Journal of Urology - October 1, 2009 Category: Urology & Nephrology Authors: Nirmal T J, Singh J C Source Type: journals

Formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Roni M A, Kibria G, Jalil RIndian Journal of Pharmaceutical Sciences 2009 71(3):252-258The aim of the present study was the determination of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin hydrochloride). Binary mixer of one hydrophilic polymer (hydroxypropylmethylcellulose) and one directly compressible Eudragit (RS PO) was used in tablets prepared by direct compression. The amounts of both polymers were taken as independent variables for the 3 2</sup&...
Source: Indian Journal of Pharmaceutical Sciences - September 25, 2009 Category: Drugs & Pharmacology Authors: Roni M A, Kibria G, Jalil R Source Type: journals

UROXATRAL (Alfuzosin Hydrochloride) Tablet, Extended Release [Sanofi-Aventis U.S. LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Sep 17, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - September 17, 2009 Category: Drugs & Pharmacology Source Type: organizations

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitroEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion: We have shown that curcumin acts on localized prostate cancer to induce apoptosis and may therefore be an option as a future therapeutic agent. (Source: International Braz J Urol)
Source: International Braz J Urol - August 22, 2009 Category: Urology & Nephrology Source Type: journals

Alfuzosin in the treatment of chronic prostatitis/chronic pelvic pain syndromeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Content Type Journal ArticleCategory Clinical Trials ReportDOI 10.1007/s11884-009-0026-yAuthors Michel Pontari, Department of Urology at the Temple University School of Medicine Philadelphia USA Journal Current Bladder Dysfunction ReportsOnline ISSN 1931-7220Print ISSN 1931-7212 Journal Volume Volume 4 Journal Issue Volume 4, Number 3 / September, 2009 (Source: Current Bladder Dysfunction Reports)
Source: Current Bladder Dysfunction Reports - August 17, 2009 Category: Urology & Nephrology Tags: Current Bladder Dysfunction Reports Source Type: journals

Alfuzosin/tamsulosin: Retrograde ejaculation and priapism: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - August 17, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Alfuzosin 10 mg Once Daily Increases the Chances of Successful Trial without Catheter after Acute Urinary Retention Secondary to Benign Prostate HyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Urol Int 2009;83:44-48 (DOI:10.1159/000224867) (Source: Karger Publishers)
Source: Karger Publishers - July 27, 2009 Category: Cancer & Oncology Source Type: journals

Re: Alfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain SyndromeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Nickel JC, Krieger JN, McNaughton-Collins M, et al; Chronic Prostatitis Collaborative Research NetworkN Engl J Med 2008;359:2663–73Expert's summaryChronic prostatitis–chronic pelvic pain syndrome (CP/CPPS) is an enigmatic syndrome that affects approximately 10% of men worldwide. The US National Institutes of Health (NIH) initiated studies >10 yr ago to systematically develop a Chronic Prostatitis Symptom Index (NIH-CPSI) and began trials with a variety of agents to ameliorate the symptoms of CP/CPPS. Prior studies had identified α-blockers as potentially effective therapy. A large multicenter randomized double-blind p...
Source: European Urology - May 31, 2009 Category: Urology & Nephrology Authors: Anthony J. Schaeffer Tags: Words of Wisdom Source Type: journals

Medication and food issues for overactive bladder/lower urinary tract symptoms: When do we eat?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article addresses the effects of food on the current treatments for OAB and LUTS and the clinical considerations for their optimal dosing with regard to food. Content Type Journal ArticleDOI 10.1007/s11884-009-0014-2Authors Helene C. MaltzDavid R. StaskinEdward Zoltan, New York Methodist Hospital One Prospect Park West, Suite C Brooklyn NY 11215 USA Journal Current Bladder Dysfunction ReportsOnline ISSN 1931-7220Print ISSN 1931-7212 Journal Volume Volume 4 Journal Issue Volume 4, Number 2 / June, 2009 (Source: Current Bladder Dysfunction Reports)
Source: Current Bladder Dysfunction Reports - May 15, 2009 Category: Urology & Nephrology Tags: Current Bladder Dysfunction Reports Source Type: journals

Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
To assess, using the psychometrically validated Male Sexual Health Questionnaire (MSHQ), the prevalence of ejaculatory dysfunction (EjD) and bother due to EjD in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH), and to assess predictors of EjD in this population. In all, 5999 sexually active men with LUTS completed the International Prostate Symptom Score (IPSS) which rates LUTS severity, and the MSHQ long-form, which evaluates seven EjD symptoms and bother due to EjD. Concomitant intake of medical treatments for BPH and previous BPH-related surgery were collected. The impact of...
Source: BJU International - May 7, 2009 Category: Urology & Nephrology Authors: Raymond C. Rosen, John M. Fitzpatrick Source Type: journals

Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic HyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: We propose that ARBs and ARIs have distinct clinical effects and, hence, should be considered for distinct groups of LUTS/BPH patients based on specific treatment goals in a given patient.Take Home Message: While both α-blockers and 5α-reductase inhibitors can reduce male lower urinary tract symptoms and prevent disease progression, their effects differ quantitatively and qualitatively, depending on the end point being studied. Combination treatment is primarily useful to prevent disease progression. (Source: European Urology Supplements)
Source: European Urology Supplements - April 1, 2009 Category: Urology & Nephrology Authors: Martin Michel, Jean de la Rosette Source Type: journals

Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In this study we test whether functional screening of compounds to adrenergic G protein-coupled receptors (GPCRs) would provide data that correlated significantly with radiolabeled binding data, thereby permitting researchers to replace expensive radioligand-binding experiments with non-radioactive screening. An increase in intracellular calcium levels represents an important second messenger signal for several recombinant GPCRs. In this study, we describe the affinities of three alpha adrenoceptor antagonists (terazosin, tamsulosin and alfuzosin), determined by monitoring the changes in intracellular calcium levels and co...
Source: Biotechnology Journal - March 18, 2009 Category: Biotechnology Authors: Nanda K, Chatterjee M, Gupta S, Singh R, Tiwar A, Gupta D, Ray A Tags: Biotechnol J Source Type: journals

Effects of Alfuzosin and Tamsulosin on Sperm Parameters in Healthy Men: Results of a ...Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ejaculation disorders are associated with tamsulosin treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH). (Source: UroToday)
Source: UroToday - February 17, 2009 Category: Urology & Nephrology Tags: Browse Categories - Erectile Dysfunction (ED) Source Type: info

Prospective Randomized Trial Comparing Efficacy of Alfuzosin and Tamsulosin in Management of Lower Ureteral Stones.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: Medical treatment of lower ureteral calculi with tamsulosin and alfuzosin resulted in a significantly increased stone expulsion rate, decreased expulsion time, and a reduced need for analgesic therapy. PMID: 19193417 [PubMed - as supplied by publisher] (Source: Urology)
Source: Urology - February 2, 2009 Category: Urology & Nephrology Authors: Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P Tags: Urology Source Type: journals

Association of Sexual Dysfunction With Lower Urinary Tract Symptoms of BPH and BPH Medical Therapies: Results From the BPH Registry.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: These results have provided additional evidence of the link between LUTS/BPH and sexual dysfunction in aging men and support clinical trial results indicating different rates of sexual side effects for BPH medical therapies. PMID: 19167031 [PubMed - as supplied by publisher] (Source: Urology)
Source: Urology - January 21, 2009 Category: Urology & Nephrology Authors: Rosen RC, Wei JT, Althof SE, Seftel AD, Miner M, Perelman MA, Tags: Urology Source Type: journals

Common Treatment For Chronic Prostatitis Fails To Reduce Symptoms, Study ShowsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 28, 2008 Category: Science Source Type: news

Common Treatment For Men's Pelvic Pain Proves Ineffective, Queen's-led Study ShowsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A commonly-prescribed drug for men suffering from a painful pelvic condition failed to significantly reduce patients' symptoms in an international study led by Queen's University professor and urologist at Kingston General Hospital, Curtis Nickel. The drug, called Alfuzosin, is regularly prescribed by more than half of family doctors to treat chronic prostititis/chronic pelvic pain syndrome. This affliction is estimated to affect from six to 12 per cent of the population. (Source: Pain / Anesthetics News From Medical News Today)
Source: Pain / Anesthetics News From Medical News Today - December 24, 2008 Category: Anesthesiology Tags: Urology / Nephrology Source Type: news

Alpha-Adrenergic Alfuzosin Not Effective for Chronic Prostatitis PainEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Contrary to expectations, the alpha-adrenergic blocker alfuzosin did not alleviate pain in men with chronic prostatitis in a placebo-controlled study conducted by investigators in the Chronic Prostatitis Collaborative Research Network. Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - December 23, 2008 Category: Urology & Nephrology Tags: Urology Source Type: info

Common Treatment for Chronic Prostatitis Fails to Reduce SymptomsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BETHESDA, Md., Dec. 17, 2008--Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 18, 2008 Category: Pharmaceuticals Source Type: news

Common Treatment for Chronic Prostatitis Fails to Reduce SymptomsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The study is to be published in the New England Journal of Medicine. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 18, 2008 Category: American Health Source Type: news

Alfuzosin May Not Be Helpful for Chronic Prostatitis-Chronic Pelvic Pain SyndromeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study does not support the use of alfuzosin for relieving the symptoms of chronic prostatitis-chronic pelvic pain syndrome in men who have not been treated with an alpha-blocker. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 17, 2008 Category: Consumer Health News Tags: Urology Source Type: news

Alpha-Blocker Therapy Shows No Benefit for ProstatitisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
KINGSTON, Ontario (MedPage Today) -- For chronic prostatitis-chronic pelvic pain syndrome, the alpha-blocker alfuzosin (Uroxatral) did no better than placebo, according to a randomized trial. (Source: MedPage Today Urology)
Source: MedPage Today Urology - December 17, 2008 Category: Urology & Nephrology Source Type: news

ORIGINAL ARTICLE: Alfuzosin and Symptoms of Chronic Prostatitis-Chronic Pelvic Pain SyndromeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In this multicenter, randomized, double-blind, placebo-controlled trial, treatment with the alpha-adrenergic receptor blocker alfuzosin (as compared with placebo) did not reduce symptoms in men who had received a diagnosis of chronic prostatitis-chronic pelvic pain syndrome in the preceding 2 years and who had not previously been treated with an alpha-adrenergic receptor blocker. The findings do not support the use of alfuzosin for men in whom chronic prostatitis-chronic pelvic pain syndrome has recently been diagnosed. (Source: New England Journal of Medicine)
Source: New England Journal of Medicine - December 17, 2008 Category: Internal Medicine Authors: Nickel, J. C., Krieger, J. N., McNaughton-Collins, M., Anderson, R. U., Pontari, M., Shoskes, D. A., Litwin, M. S., Alexander, R. B., White, P. C., Berger, R., Nadler, R., O'Leary, M., Liong, M. L., Zeitlin, S., Chuai, S., Landis, J. R., Kusek, J. W., Nyb Tags: ORIGINAL ARTICLES Source Type: journals

Sexuality and the management of BPH with alfuzosin (SAMBA) trialEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Lee & S-J Yoo (Source: International Journal of Impotence Research)
Source: International Journal of Impotence Research - December 11, 2008 Category: Urology & Nephrology Authors: B-H ChungJ-Y LeeC-I KimC-S KimC-Y OhS-W LeeJ-S LeeS-J Yoo Source Type: journals

Alfuzosin to Relieve Ureteral Stent Discomfort: A Prospective, Randomized, Placebo Controlled StudyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Purpose: We assessed the impact of alfuzosin on ureteral stent discomfort.Materials and Methods: A total of 66 patients scheduled for unilateral retrograde ureteroscopy with stent placement provided consent for the study. Patients were randomized between placebo and the study medication, and investigators and patients were blinded to the randomization scheme. To evaluate pain and urinary symptoms patients were asked to complete the Ureteral Stent Symptom Questionnaire (Stone Management Unit, Southmead Hospital, Westbury-on-Trym, United Kingdom) before ureteroscopy and 3 days after the procedure to minimize the confounding ...
Source: The Journal of Urology - December 9, 2008 Category: Urology & Nephrology Authors: Richard Beddingfield, Renato N. Pedro, Bryan Hinck, Carly Kreidberg, Kendall Feia, Manoj Monga Tags: Trauma/Reconstruction/Diversion Source Type: journals

Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction. Preliminary ReportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions. Combined therapy improved ED and LUTS as demonstrated by the significant improvement in uroflowmetry measures and in IPSS and IIEF-EF scores. A significant improvement was also observed in quality of life assessments. The beneficial effects of tadalafil on LUTS similar to the benefits of alfuzosin on ED, although present, were smaller. Liguori G, Trombetta C, Giorgi GD, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, and Belgrano E. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: An integrated approach to the management of patients with lower urinary tract symptoms and e...
Source: The Journal of Sexual Medicine - December 4, 2008 Category: Sexual Medicine Authors: Giovanni Liguori, Carlo Trombetta, Gioacchino De Giorgi, Giorgio Pomara, Giuseppe Maio, Daniele Vecchio, Giuseppe Ocello, Giangiacomo Ollandini, Stefano Bucci, Emanuele Belgrano Source Type: journals

Effect of alfuzosin on female primary bladder neck obstructionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Abstract Our objective was to assess the effect of the selective α1-blocker alfuzosin on urodynamic parameters and quality of life in female patients with primary bladder neck obstruction (PBNO). Twenty-five women identified as having PBNO were included in the study. After the initial assessment of urodynamic parameters and bother score index, all patients were treated with alfuzosin 5 mg twice daily for 8 weeks. After this period of time, the patients were reassessed with the same methodology as pretreatment. Symptoms subjectively improved, and patients’ satisfaction significantly increased in ...
Source: International Urogynecology Journal - November 4, 2008 Category: OBGYN Tags: International Urogynecology Journal Source Type: journals

Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstructionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This study suggests a rationale for further clinical trials using combinations of [alpha]-adrenoceptor antagonists and phosphodiesterase-5 inhibitors in patients with ED and lower urinary tract symptoms. (Source: BJU International)
Source: BJU International - October 17, 2008 Category: Urology & Nephrology Authors: Serap Gur, Suresh C. Sikka, Surabhi Chandra, Padma Sandeep Koka, Krishna C. Agrawal, Philip J. Kadowitz, Wayne J.G. Hellstrom Source Type: journals

Alfuzosin Stone Expulsion Therapy for Distal Ureteral Calculi: A Double-Blind, Placebo Controlled Study: From F1000Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Alpha blockers for stone expulsions--Can they help reduce the severe pain? Ranked "must read" from F1000. Faculty of 1000 Medicine (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 19, 2008 Category: Drugs & Pharmacology Tags: Internal Medicine Source Type: info

Stone Disease - Randomized Clinic Trials Suggest Lack Of Benefit To Alpha Blocker Therapy For Ureteral CalculiEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) There were several randomized clinic trials that suggested a lack of benefit to alpha blocker therapy for Ureteral calculi. Abstract 1491 evaluated tamsulosin vs placebo and Abstract 1410 compared alfuzosin to placbo in untreated patients trying to pass a Ureteral stone. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 6, 2008 Category: Consumer Health News Source Type: news

[Prevalence of ejaculatory dysfunction secondary to alpha-blocker therapy in patients with benign prostatic hyperplasia]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
INTRODUCTION: Benign prostatic hyperplasia (BPH) is characterized by lower urinary tract symptoms (LUTS) that may cause ejaculatory disorders, although they could be also a consequence of alpha-blocker treatment. OBJECTIVES: To determine the prevalence of ejaculatory dysfunction in patients with HBP undergoing alpha-blocker therapy. Secondary objectives were to evaluate the effect of different drugs on normal ejaculation and the relationship of dysfunction degree to prognostic factors and BPH severity. MATERIALS AND METHODS: Epidemiologic, transversal, uncontrolled and open-label study in 1.177 patients older than 40, ...
Source: Actas Urologicas Espanolas - July 1, 2008 Category: Urology & Nephrology Authors: Martín-Morales A, Meyer G, Ramírez E Tags: Actas Urol Esp Source Type: journals

Effects Of Alpha-Blocker On Ureteral Dynamics With And Without A Ureteral Stone: An In Vivo Porcine StudyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, FL (UroToday.com) - Medical expulsive therapy for ureteral calculi has been established in several randomized controlled clinical trials. However, the exact mechanism of action and the extent of their influence on renal pelvic and ureteral dynamics has not been elucidated. In a novel model, Das and colleagues from Saint Louis, Missouri studied the effects of an oral alpha blocker (alfuzosin HCL) on ureteral peristalsis, intrapelvic pressure (IPP) and stone movement. (Source: Urology / Nephrology News From Medical News Today)
Source: Urology / Nephrology News From Medical News Today - June 20, 2008 Category: Urology & Nephrology Source Type: news

Alfuzosin Stone Expulsion Therapy For Distal Ureteral Calculi: A Double-Blind Placebo-Controlled StudyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, FL (UroToday.com) - Medical expulsive therapy for the management of distal ureteral calculi has been shown in several randomized controlled trials to decrease the time to stone expulsion and to increase the stone passage rate. In a new study with the alpha blocker alfuzosin, Pedro and colleagues from Minnesota performed a randomized controlled double blind study to evaluate the efficacy of alfuzosin for medical expulsive therapy for distal ureteral stone passage. (Source: Urology / Nephrology News From Medical News Today)
Source: Urology / Nephrology News From Medical News Today - June 19, 2008 Category: Urology & Nephrology Source Type: news

The Effect Of Alfuzosin And Tolterodine In Treating Double-J Stent-Related SymptomsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, FL (UroToday.com) - In this Level I prospective randomized study, either alfuzosin (10 mg) or tolterodine (4mg) per day, resulted in a statistically significant equal decrease in ureteral stent symptoms. However, the overall decrease for either drug was only 21%.Of interest, but understandable, the pain index decreased more with alfuzosin ( a 50% drop) while the symptoms of bladder irritation decreased more with tolterodine (but only by 8-21%). (Source: Urology / Nephrology News From Medical News Today)
Source: Urology / Nephrology News From Medical News Today - June 15, 2008 Category: Urology & Nephrology Source Type: news

Alfuzosin Treatment Of Recently Diagnosed And Newly Symptomatic Alpha-blocker NaÃ¯ve Patients With Chronic Prostatitis/Chronic Pain SyndromeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, FL (UroToday.com) - Results from the NIH Randomized Multicenter Double-Blind Placebo Controlled Trial. Dr. Nickel presented the use of alfuzosin in the treatment of chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). CP is extremely prevalent with 6-9% of men suffering from this. Treatment of CP is more costly in North America than treatment for type II diabetes mellitus, he said. (Source: Urology / Nephrology News From Medical News Today)
Source: Urology / Nephrology News From Medical News Today - June 12, 2008 Category: Urology & Nephrology Source Type: news

Uroxatral(Alfuzosin Hydrochloride) Tablet, Extended Release [Sanofi-Aventis U.S. LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Apr 18, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - April 18, 2008 Category: Drugs & Pharmacology Source Type: organizations

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practiceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BJU International, Volume 101, Issue 7, Page 847-852, April 2008. Study Type – Therapy (individual cohort study)Level of Evidence 2b OBJECTIVES To assess the 3-year efficacy and safety of the selective α1-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign ... (Source: BJU International)
Source: BJU International - March 5, 2008 Category: Urology & Nephrology Tags: article Source Type: journals

Combination of Alfuzosin and Tadalafil Exerts In Vitro an Additive Relaxant Effect on Human Corpus CavernosumEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Journal of Sexual Medicine, Volume 0, Issue 0, Page ???, OnlineEarly Articles. ABSTRACT Introduction. Phosphodiesterase type 5 (PDE5) inhibitors, such as tadalafil, are a first-line treatment for erectile dysfunction (ED). Nevertheless, some patients do not respond to this treatment. Clinical data suggest that the addition of α1-... (Source: The Journal of Sexual Medicine)
Source: The Journal of Sexual Medicine - January 22, 2008 Category: Sexual Medicine Tags: article Source Type: journals

Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individualsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion Different alpha-blockers, which are used during different time frames in the same individuals, provide similar efficiency outcome. When the desired effect in the treatment for BPH could not be obtained with one alpha-blocker, there may not be any benefit in switching to another one. Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s11255-007-9312-9Authors Temucin Senkul, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyOmer Yilmaz, Gulhane Military Medical Faculty Istanbul, Uskudar 34668 TurkeyCuneyt Iseri, Gulhane Military Medical Faculty Istanbul, Uskudar 346...
Source: International Urology and Nephrology - December 16, 2007 Category: Urology & Nephrology Tags: International Urology and Nephrology Source Type: journals

Uroxatral(Alfuzosin) Tablet, Extended Release [Sanofi-Aventis U.S. LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Dec 10, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - December 10, 2007 Category: Drugs & Pharmacology Source Type: organizations

Effects of Alfuzosin 10 mg Once Daily on Sexual Function in Men Treated for Symptomatic Benign Prostatic HyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This randomized, double-blind, placebo-controlled study describes the effects of 10 mg of alfuzosin daily on erectile and ejaculatory function in men with symptomatic BPH. International Journal of Impotence Research (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - October 1, 2007 Category: Urology & Nephrology Tags: Urology Source Type: info

Uroxatral(Alfuzosin) Tablet, Extended Release [Sanofi-Aventis U.S. LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Sep 28, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - September 28, 2007 Category: Drugs & Pharmacology Source Type: organizations

Barr confirms UROXATRAL patent challengeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg. (Source: News-Medical News Feed)
Source: News-Medical News Feed - September 26, 2007 Category: Consumer Health News Source Type: news

Barr Confirms Patent Challenge of UROXATRAL(R)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WOODCLIFF LAKE, N.J., Sept. 25 (HSMN NewsFeed) -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its URO... Biopharmaceuticals, Generics, LitigationBarr Pharmaceuticals, UROXATRAL, alfuzosin, sanofi-aventis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2007 Category: Pharmaceuticals Source Type: news

Effects of Alfuzosin 10 mg Once Daily on Sexual Function in Men Treated for Symptomatic Benign ...Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
New England Research Institutes, Watertown, MA, USA. (Source: UroToday)
Source: UroToday - September 3, 2007 Category: Urology & Nephrology Tags: Browse Categories - Bladder Cancer Diagnosis and Monitoring Center Source Type: info

Alfuzosin-induced Acute Liver Injury.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We describe a 56-year-old man who developed an acute liver injury after taking alfuzosin for 1 month to control his newly diagnosed benign prostatic hypertrophy (BPH). There was no history of alcohol consumption or the taking herbal or traditional remedies. Viral causes, autoimmune hepatitis, and biliary tree obstruction were excluded. Other rare causes of hepatitis such as hemochromatosis, primary biliary cirrhosis and Wilson's disease were also absent in this patient. His liver test results began to improve after discontinuing the alfuzosin. Two weeks later, alfuzosin was administered again because the patient complained...
Source: Korean J Hepatol - September 1, 2007 Category: Gastroenterology Authors: Kim SY, Kim BH, Dong SH, Kim HJ, Chang YW, Chang R, Kim YW Tags: Korean J Hepatol Source Type: journals

Uroxatral(Alfuzosin Hydrochloride) Tablet, Extended Release [Sanofi-Aventis U.S. LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 30, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 30, 2007 Category: Drugs & Pharmacology Source Type: organizations

Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasiaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia International Journal of Impotence Research advance online publication, August 23, 2007. doi:10.1038/sj.ijir.3901554 Authors: R Rosen, A Seftel & C G Roehrborn (Source: International Journal of Impotence Research)
Source: International Journal of Impotence Research - August 23, 2007 Category: Urology & Nephrology Authors: R RosenA SeftelC G Roehrborn Source Type: journals